The Pharis Group with the parent companies Pharis Pharma Holding GmbH & Co. KG and Pharis Biotec GmbH performs the operational activities together with the subsidiaries Cardiopep Pharma GmbH, VIRO Pharmaceuticals GmbH & Co. KG, Haemopep Pharma GmbH and IPF Pharmaceuticals GmbH.